Beynleumi Hanpakot 2025: The Balance Sheet Jumped, but the Equity Cushion Barely Moved

Getting to Know the Company

Beynleumi Hanpakot is not a bank in the operating sense, and it is not a credit company that is supposed to generate its own lending spread. It is a funding wrapper for the International Bank. The company raises bonds, subordinated notes, and commercial paper, and deposits the full proceeds with the bank on identical terms. So the core economic question here is not how much the company "grew." It is whether the funding structure stayed clean, whether market access remains open, and whether bondholders still have a clear protection layer even as the balance sheet expands.

What is working now? The basic structure did not break. The International Bank still bears all of the company's ongoing expenses, the indemnity letter remains in place, the company complied with the trust deeds, and no grounds existed for immediate acceleration. The ratings also remained strong: the bonds are rated ilAAA by S&P Maalot and Aaa.il by Midroog, and the company received first-time short-term ratings for its commercial paper in August 2025.

But the picture is still not fully clean. In 2025 total assets rose to NIS 6.84 billion from NIS 4.48 billion, a 52.4% increase, while equity rose only to NIS 33.3 million from NIS 31.6 million, a 5.6% increase. The equity-to-assets ratio fell to 0.49% from 0.70%, and liabilities rose to about 204 times equity. That does not mean the company moved into distress, because the liabilities are matched by deposits at the bank and backed by an indemnity. It does mean, however, that the wrapper's standalone equity cushion remained tiny even after a year of sharp balance-sheet growth.

There is also an important reading trap here. Finance income of NIS 219.1 million and finance expense of NIS 216.4 million look, at first glance, like a large and profitable business. That is misleading. Net profit was only NIS 1.753 million for the year, and the fourth quarter already showed how violently the gross lines can move without changing the economics of the company very much. This is a bond-only issuer, with no listed equity and no short-interest layer. Market interpretation therefore runs through the debt, the rollover calendar, and the ratings, not through any dream of a new earnings engine.

What is not obvious at first glance:

• 2025 was mainly a funding-mix year. The company added bond series 13 and commercial-paper series 1 and 2, and in the same year fully redeemed series 10. This was not just balance-sheet growth. It was also a shift toward a partly shorter structure.
• Commercial paper became material almost overnight. By year-end it already stood at NIS 2.442 billion, about 35.9% of total liabilities.
• Shareholder-accessible value stayed very small. Distributable profits stood at NIS 3.381 million at the end of 2025, and the company has no dividend policy.
• Part of the debt here is not ordinary debt. The subordinated notes, with a carrying value of NIS 2.280 billion, include loss-absorption mechanics and count as Tier 2 capital for the International Bank.

The economic map looks like this:

Events and Triggers

2025 was not a year of operating improvement in the usual sense. It was a year in which the funding taps reopened, and the company used them to build a larger and partly shorter structure.

Trigger one: in January 2025 the validity of the 2023 shelf prospectus was extended until February 1, 2026. That was not dramatic by itself, but it gave the company the practical framework to keep issuing through the year.

Trigger two: on September 4, 2025 the company issued bond series 13 with NIS 1.7 billion par value and commercial-paper series 1 with NIS 1.3 billion par value. A few days later, on September 10, it fully redeemed bond series 10. This is a key point, because it shows that the company was not only expanding the balance sheet. It was also replacing part of the old structure with a new mix of longer-dated debt and much shorter paper.

Trigger three: on November 26, 2025 the company issued commercial-paper series 2 in the amount of NIS 1.118665 billion. From that point on, the company could no longer be read as a simple linked-bond wrapper. The short layer had become a major funding engine.

Trigger four: on February 25, 2026, after the balance-sheet date, the company published a new shelf prospectus. That is a clear signal that the 2026 story will be read mainly through the question of whether the issuance window remains open, not through whether annual profit moves by another few hundred thousand shekels.

Trigger five: on February 3, 2026 the International Bank received an invitation from FIBI Holdings to enter negotiations for a tax-exempt merger. The company itself stresses that there is no certainty regarding the transaction, its terms, or its timing. This is still not a direct earnings event for Beynleumi Hanpakot, but it matters because the whole chain of indemnity, consolidation, and regulatory relief runs through the group structure.

What really matters is not only the net number, but also the gross movement. In 2025 the company added NIS 4.118665 billion of new issuance and repaid NIS 1.936933 billion of bonds. That is one reason the balance sheet grew so fast, and it is also one reason 2026 looks like a clear rollover year.

Efficiency, Profitability, and Competition

This is not a company to analyze through gross margin, revenue per employee, or classic market share. The right reading is simpler and harsher: does the structure remain symmetrical, do funding costs and deposit income keep moving together, and is the market still willing to finance the wrapper on reasonable terms?

The Revenue Line Tells You Almost Nothing

In 2025 finance income fell 11.8% to NIS 219.1 million, while finance expense fell 11.7% to NIS 216.4 million. Finance profit before tax was NIS 2.71 million, versus NIS 3.23 million in 2024. That is a decline, but it is tiny relative to the volatility in the gross lines.

The fourth quarter makes this clear. Finance income dropped to NIS 37.6 million, after NIS 80.7 million in the second quarter and NIS 78.3 million in the third. A headline reader would think something dramatic happened. In practice, finance expense fell by almost the same amount, and quarterly profit still came in at NIS 456 thousand. This is not a business that suddenly improved or deteriorated in the fourth quarter. It is a business in which linkage and fair-value measurement move, while the true margin remains extremely thin.

Where the Profit Actually Comes From

Beynleumi Hanpakot's profit is not the result of strong "distribution" or of a new operating engine. It comes from investing the active capital, from small differences between fair value and amortized cost, and from tax.

And 2025 actually shows what happens when those thin margins get squeezed. The expected-credit-loss allowance on financial assets measured at amortized cost rose to NIS 1.357 million from NIS 679 thousand at the end of 2024, and the change in the allowance reduced finance income by NIS 678 thousand, versus only a negligible positive contribution of NIS 18 thousand in 2024. At the same time, tax expense fell to NIS 957 thousand from NIS 1.081 million, mainly because profit before tax also declined.

Another important point is that there is barely any independent expense layer here. General and administrative expenses were NIS 308 thousand in 2025, and they were fully offset by reimbursement from the International Bank. The workforce is not independent either: the directors and CEO are bank employees, and the company receives the required manpower services at no charge. In other words, this is not a company that needs to "become more efficient." It needs to remain a clean funding structure.

Competition Is About Market Access, Not Margin

The company says its main competitors are other issuers of debt instruments with similar ratings. That matters, but it needs sharpening. The competition here is not for end customers. It is for pricing, demand, and rating discipline.

In that sense, 2025 was a good year. In August the commercial paper received first-time short-term ratings, and in November S&P Maalot revised the outlook on the International Bank from negative to stable and reaffirmed the issuer's debt ratings. That is an important outside signal. In Beynleumi Hanpakot, the competitive edge does not come from the company's own selling ability. It comes from the link to a highly rated bank and from staying a credible funding channel for that bank.

Cash Flow, Debt, and Capital Structure

The cash framing matters here. In Beynleumi Hanpakot, the right lens is all-in cash flexibility at the wrapper level: how much cash really remains after all actual cash uses. The answer is that very little should remain, because most of the cash that comes in is passed almost immediately into matching deposits at the bank.

The Cash-Flow Statement Looks Small Because the Wrapper Is Not Meant to Hold Cash

Cash flow from operating activity was only NIS 620 thousand in 2025. That looks almost absurd against a NIS 6.84 billion balance sheet, but it actually tells the right story. The company is not meant to produce meaningful free cash flow on its own. It is meant to move issuance proceeds into bank deposits, receive matching interest, pay instrument holders, and keep only a very small gap driven by active capital, expected-credit-loss provisioning, and tax.

The real picture appears when you combine investing and financing cash flows. In 2025 investing activity used NIS 2.182 billion, mainly because the company placed NIS 2.450 billion into short-term deposits and NIS 1.704 billion into long-term deposits, offset by repayments of existing deposits. Financing activity, meanwhile, generated NIS 2.182 billion, mainly from NIS 2.419 billion of commercial-paper issuance and NIS 1.7 billion of series 13 bonds, offset by NIS 1.937 billion of bond repayments. Year-end cash was only NIS 510 thousand.

That is not classic cash-flow weakness. It is evidence that the company truly behaves like a conduit. Anyone looking for free cash flow here is looking at the wrong model.

The Debt Structure Became Shorter

At the end of 2025 commercial paper stood at NIS 2.442 billion, bonds at NIS 2.081 billion, and subordinated notes at NIS 2.280 billion. In carrying-value terms, the three layers are now close in size. In risk terms, they are very different.

The more important number is the contractual maturity ladder. Undiscounted contractual cash flows of all financial liabilities reached NIS 7.939 billion at the end of 2025, versus NIS 5.421 billion at the end of 2024. Out of that, NIS 45.4 million fell due within six months, and another NIS 2.835 billion within 6 to 12 months. In other words, almost NIS 2.88 billion sits inside the first 12 months.

What Actually Protects Bondholders

There are three clear anchors. First, issuance proceeds are deposited with the International Bank on terms identical to each series. Second, the bank undertook to bear all payments to holders and all issuance and ongoing expenses. Third, the company operates with a full indemnity letter from the bank, and on that basis also enjoys relief from certain capital-adequacy and borrower-limit rules as long as the relevant conditions are met.

That is the heart of the story: repayment strength here is not the strength of an independent company that built its own earnings engine. It is the strength of a back-to-back structure supported by the International Bank and by a tailored regulatory framework.

What Does Not Really Belong to Shareholders

The easy mistake is to see a NIS 6.84 billion balance sheet and assume there is a thick value layer sitting above the debt. That is wrong. Equity is only NIS 33.3 million, and distributable profits are NIS 3.381 million. In other words, most of the value created here is the operating and regulatory value of a funding channel for the bank, not a value layer that accumulates comfortably for the company's own shareholder.

Outlook

2026 looks like a funding bridge year, not an earnings breakout year. There is no explicit profit guidance in the filing, and for good reason. In a structure like this, the important question is not whether profit rises from NIS 1.8 million to NIS 2.0 million. The important question is whether the funding structure built in 2025 passes its first real tests without friction.

Four points to lock in now:

• The first test is rollover, not profit. CP series 1 and 2, totaling NIS 2.442 billion, fall due in September and November 2026.
• The second test is management of the subordinated-capital layer. Series 25 has a possible early-call window in June to July 2026, and if it is not called the coupon resets.
• The third test is preserving the rating picture. In 2025 the company benefited from affirmed ratings and a stable outlook for the bank. That matters far more than the income line.
• The fourth test is structural clarity. If the FIBI-bank merger discussion progresses, the market will want to see that the structure supporting the issuer, indemnity, consolidation, and supervision, remains clear and intact.

What Must Happen Over the Next 2 to 4 Quarters

First, the company needs to pass through the commercial-paper rollover smoothly. This is not a small technical event. After 2025, the market will test whether series 1 and 2 were a one-off opening or a durable funding layer.

Second, the market will watch what happens around series 25. During the June to July 2026 window the company has a one-time option to redeem early. If it does not, the interest rate will reset against the original anchor. This is not an existential drama, but it is the first real signal about how the bank and the issuer think about managing this capital layer.

Third, the market will read the ratings not only as a stability badge, but as a pricing signal. As long as ratings remain in place and market access stays open, the wrapper's thin equity structure is less alarming. If that tone weakens, the thin standalone buffer will immediately move back to center stage.

What the Market May Miss on First Read

A fast reader can fall into two opposite mistakes. One is to see the balance sheet jump and assume there is a growth engine here. The other is to see the tiny profit and assume nothing changed. Both are wrong. 2025 was not a business-growth year. It was a year of rebuilding the funding mix. That is why what will change the market reading in the short term is not EBITDA or return on equity, but market access, issuance pricing, and rollover execution.

What Could Improve the Reading and What Could Weigh on It

What would improve the reading is a quiet sequence of funding actions: smooth rollover of the commercial paper, preserved ratings, and continued ability to issue without an unusual risk premium.

What would weigh on the reading is any sign that the market demands a higher price for the short layer, that the tone from rating agencies changes, or that structural clarity around the group weakens. In a normal company that might be a footnote. Here it is the whole story.

Risks

The risks in Beynleumi Hanpakot are not operational. They are structural. So they need to be named precisely.

Single-Counterparty Risk

The company deposits all issuance proceeds with the International Bank, and its ability to meet obligations depends on repayment of those deposits and subordinated deposits by that same bank. This is a simple and efficient structure, but it is also highly concentrated. There is no diversification here.

A Very Thin Standalone Equity Cushion

NIS 33.3 million of equity against a NIS 6.84 billion balance sheet is not a buffer designed to absorb large standalone shocks. Again, that is not necessarily a flaw in this model as long as bank support remains full. It does mean that the wrapper itself is building almost no internal safety layer.

Rollover Risk Has Become Much More Material

The move into NIS 2.442 billion of commercial paper changes the reading. In 2024 there was no commercial-paper layer at all. By the end of 2025 it had become the largest component of the structure. As long as the market stays open, that is flexible. If the issuance window becomes less comfortable, it immediately turns into a pressure point.

Not All of the Debt Here Is Plain Senior Debt

The subordinated notes in series 25 to 27 include a loss-absorption mechanism if the International Bank's CET1 ratio falls below 5% or in a non-viability event. That is not a technical footnote. It is a reminder that a major part of the structure is meant to serve as regulatory capital for the bank and therefore needs to be read differently from plain senior debt.

Regulatory Support Is Part of the Thesis

The exemption from capital-adequacy measurement rules and borrower-limit rules depends on the company meeting the relevant conditions, being included in consolidation, and holding the bank's indemnity letter. That is a structural advantage, but also a condition that requires continued clarity around the support chain.

Conclusions

Beynleumi Hanpakot ends 2025 in a stable position, but that stability is not independent. It rests on three anchors: matching deposits with the International Bank, a full indemnity letter, and a capital market still willing to finance the wrapper. That is the side supporting the thesis.

The main friction is that in the same year the balance sheet jumped 52.4%, the equity cushion barely moved, and the company also added a very large short-term funding layer. So 2026 will not be judged through net profit. It will be judged through whether this machine can keep rolling with the same degree of cleanliness now that the short layer is already material.

What will shape the market reading over the short to medium term is a very clear sequence: smooth rollover of CP series 1 and 2, stable ratings, and orderly handling of the first early-call window in series 25. If those three pass quietly, the thin equity base will look less dramatic. If one of them cracks, the whole reading becomes harder immediately.

Current thesis in one line: Beynleumi Hanpakot remains a stable funding conduit for the International Bank, but 2025 greatly increased the balance sheet and short-term rollover dependence without building a meaningful standalone equity cushion in parallel.

What changed: Until 2024 this was mainly a longer-dated bond wrapper with small and stable profit. By the end of 2025 it had become a much larger structure, with NIS 2.442 billion of commercial paper, a new bond series, and a short maturity wall that has become genuinely material.

Counter thesis: One could argue that the concern over thin equity is overstated because every liability is backed by a matching deposit at the bank, the bank bears all expenses and provides a full indemnity, ratings remained strong, and there were no grounds for immediate acceleration at year-end. In that type of structure, small equity may matter less than it seems at first glance.

Why this matters: In a bank funding vehicle like this, the real question is not growth or margin. It is whether market access and bank support remain strong enough to carry a huge balance sheet on an extremely small standalone capital base.

Over the next 2 to 4 quarters, what has to happen is clear: the market needs to stay open for the commercial-paper layer, the ratings need to stay stable, and the first call-or-reset event in the subordinated capital layer needs to pass without friction. What would undermine the thesis is any sign of weaker market access, a change in rating tone, or a loss of clarity in the support chain linking the issuer to the International Bank.